Insmed Inc. (INSM) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Insmed Inc. (INSM)

INSM 189.58

-2.5%

3:59 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: mopgcw	4/18/2006 4:39:56 AM
	of 136

Insmed Inc. (INSM), Glen Allen, Va. Dow Chemical Co. (DOW), Midland, Mich. Business: Endocrine, Biomanufacturing DOW’s Dowpharma subsidiary will use its Pseudomonas-based Pfenex Expression Technology to produce INSM’s iPlex mecasermin rinfibate. iPlex is approved to treat growth failure in children with severe primary IGF-1 deficiency (IGFD) or with growth hormone (GH) gene deletion who have developed neutralizing antibodies to GH. iPlex is a combination of insulin-like growth factor-1 (IGF-1) and its major binding protein (IGFBP-3).

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next